← Evidence map

ArticlePLoS biology2023

Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers.

Jonathan B Coulter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37104249